Clinical Trial Update: Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing second-line doublet chemotherapy (FOLFOX or FOLFIRI) plus Fruquintinib versus plus Bevacizumab in metastatic colorectal cancer; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Metastatic Colorectal Carcinoma (mCRC) | Phase 2 | Status: NOT_YET_RECRUITING